Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06488261

Long Term Follow-Up for Safety of AVR-RD-02

Sponsor: John Bernat

View on ClinicalTrials.gov

Summary

The goal of this observational study is to assess the safety and tolerability of AVR-RD-02 treatment in subjects who previously received AVR-RD-02 treatment (single dose administration).

Official title: A Long-Term Follow-Up Safety Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

2

Start Date

2024-02-21

Completion Date

2037-10

Last Updated

2025-07-22

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

AVR-RD-02

No study drug is administered in this study. Subjects who received AVR-RD-02 in a separate parent trial will be evaluated in this trial for long-term safety.

Locations (1)

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States